Valneva SE ADR
Price & Volume
Stats
See moreOpen | $6.24 |
Previous Close | $6.05 |
Day Range | $6.16-$6.59 |
52W Range | $5.06-$12.25 |
Market Cap | $562.3M |
Shares Short | 152,470 |
Financials
See moreRevenue (12 Mos) | $156.3M |
Revenue Growth (YoY) | -37.2% |
Gross Profit (12 Mos) | -$39.2M |
Diluted EPS | -$1.85 |
News
See moreYahoo Finance • 30 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
Yahoo Finance • last month
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Valneva SE – VALN
Yahoo Finance • 2 months ago
Jefferies Reiterates Buy Rating on Valneva (VALN) After Phase 3 Data
Yahoo Finance • 2 months ago
Pfizer Lyme Vaccine Data Adds New Angle To Vaccine Portfolio Story
About
CEO | Mr. Thomas Lingelbach |
Address | 6 rue Alain Bombard, Saint-Herblain, France, 44800 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 674 |